---
title: "\"Performance\" ZENSUN ENT's annual loss narrowed to 2.182 billion yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233798676.md"
description: "ZENSUN ENT announced its full-year results for the year ended last December, with a revenue of RMB 9.542 billion, a year-on-year decrease of 52.4%. The loss narrowed to RMB 2.182 billion, compared to a loss of RMB 2.298 billion in the same period last year; the loss per share was 1.14. No dividend was declared"
datetime: "2025-03-31T01:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233798676.md)
  - [en](https://longbridge.com/en/news/233798676.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233798676.md)
---

# "Performance" ZENSUN ENT's annual loss narrowed to 2.182 billion yuan

ZENSUN ENT (00185.HK) announced its full-year results for the year ended last December, with a revenue of RMB 9.542 billion, a year-on-year decrease of 52.4%. The loss narrowed to RMB 2.182 billion, compared to a loss of RMB 2.298 billion in the same period last year; the loss per share was 114 cents. No dividend was declared

### Related Stocks

- [00185.HK](https://longbridge.com/en/quote/00185.HK.md)

## Related News & Research

- [07:21 ETNetgain Continues to Reshape Accounting with AI, Previewing a New Consolidation Engine at Its Second Annual Accounting Summit](https://longbridge.com/en/news/290685791.md)
- [SG Group says Hong Kong Weiye Software completes HK$198.52 million purchase of 74.91% stake](https://longbridge.com/en/news/290508350.md)
- [Iraq plans to restore crude oil output to pre-crisis levels](https://longbridge.com/en/news/290352975.md)
- [Brait publishes audited annual financial statements for year ended March 31, 2026](https://longbridge.com/en/news/290788707.md)
- [CARsgen Wins First-Ever Global Approval for Solid-Tumor CAR T Therapy in China](https://longbridge.com/en/news/290409322.md)